Training and Fidelity Monitoring of Alcohol Treatment Interventions Integrated Into Routine Tuberculosis Care in Tomsk, Russia: the IMPACT Effectiveness Trial.
Saved in:
| Title: | Training and Fidelity Monitoring of Alcohol Treatment Interventions Integrated Into Routine Tuberculosis Care in Tomsk, Russia: the IMPACT Effectiveness Trial. |
|---|---|
| Authors: | Connery, Hilary (AUTHOR), Greenfield, Shelly (AUTHOR), Livchits, Viktoriya (AUTHOR), McGrady, Lana (AUTHOR), Patrick, Nickolette (AUTHOR), Lastimoso, Charmaine S. (AUTHOR), Heney, Jessica H. (AUTHOR), Nelson, Adrianne Katrina (AUTHOR), Shields, Alan (AUTHOR), Stepanova, Yekaterina P. (AUTHOR), Petrova, Lidia Y. (AUTHOR), Anastasov, Oleg V. (AUTHOR), Novoseltseva, Olga I. (AUTHOR), Shin, Sonya S. (AUTHOR) |
| Source: | Substance Use & Misuse. Jul2013, Vol. 48 Issue 9, p806-792. 9p. 1 Diagram, 1 Chart. |
| Subjects: | Tuberculosis treatment, Substance abuse diagnosis, Clinical medicine, Focus groups, Evaluation of medical care, Research funding, Teleconferencing, Transcultural medical care, Thematic analysis, Patient-centered care, Evaluation of human services programs, Physicians' attitudes |
| Geographic Terms: | Russia |
| Abstract (English): | IMPACT (Integrated Management of Physician-Delivered Alcohol Care for Tuberculosis patients) is a randomized, controlled effectiveness trial based in Tomsk, Russia, that assesses the effect of oral naltrexone and brief behavioral counseling on tuberculosis outcomes and alcohol use in 200 patients. Tuberculosis physicians without addiction experience delivered interventions as part of routine care over a 6-month period, focusing on alcohol intake reduction to support successful tuberculosis treatment. We describe design, training, and fidelity monitoring using a Russian and American team of physicians, bilingual coders, and supervisors. Culturally appropriate adaptations, limitations, and implications for future trials are discussed. The clinical trial identification number is NCT00675961. Funding came from the National Institutes of Health and National Institute on Drug Abuse. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): | Capacitación y monitoreo de una intervención para tratar problemas de alcohol integrado como parte de los cuidados de tuberculosis en un hospital en Tomsk, Rusia: el ensayo clínico de efectividad IMPACT IMPACT es un ensayo clínico de efectividad, basado en Tomsk, Rusia, que evalúa los efectos del naltrexone oral y una breve terapia de conducta sobre los resultados de tuberculosis y el uso de alcohol en 200 pacientes. Médicos que especializan en tuberculosis sin experiencia con dependencia a los sustancias hicieron intervenciones como parte del cuidado medico rutinario durante 6 meses. Las terapias se enfocaron en la reducción del consumo de alcohol para apoyar el tratamiento de tuberculosis. En este articulo explicamos el diseño, la capacitación, y el monitoreo de fiabilidad por un equipo de médicos, codificadores bilingües y supervisores de Rusia y Estados Unidos. Se ha adaptado las intervenciones para ser adecuada a la cultura y los límites del estudio. Las implicaciones para futuros ensayos clínicos son examinados. El número de identificación del ensayo clínico es: NCT00675961. Fondos provinieron del NIH y NIDA. [ABSTRACT FROM AUTHOR] |
| Abstract (French): | Formation et suivi de la fidélité des interventions pour le traitement de l'alcoolisme intégrés dans les soins routiniers contre la tuberculose à Tomsk, en Russie: le test d'efficacité IMPACT IMPACT est un essai clinique d'efficacité, aléatoire et contrôlé, basé à Tomsk, Russie, qui évalue les effets du naltrexone oral et d'une brève thérapie comportemental sur l'évolution de la tuberculose et la consommation d'alcool parmi 200 patients. Des médecins spécialisés en tuberculose, sans expérience dans la dépendance, effectuèrent des interventions dans le cadre de soins médicaux routiniers durant 6 mois, en se concentrant sur la réduction de la consommation d'alcool de manière à soutenir le traitement contre la tuberculose. Nous décrivons la conception, la formation et le contrôle de fiabilité de notre étude, réalisés avec une équipe de médecins, de codeurs bilingues et de superviseurs Russes et Américains. Les adaptations culturellement appropriées, les limites et les conséquences pour les essais cliniques futurs sont examinés. Le numéro d'identification de l'essai est NCT00675961. Financement obtenu du NIH et NIDA. [ABSTRACT FROM AUTHOR] |
| Copyright of Substance Use & Misuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
